High prevalence of hypercoagulable states in patients with recurrent thrombosis of mechanical heart valves

Basit Öğe Kaydı
dc.contributor.authorGençbay, Murat
dc.contributor.authorTuran, Fikret
dc.contributor.authorDeğertekin, Muzaffer
dc.contributor.authorEkşi Duran, Nilüfer
dc.contributor.authorMutlu, Bülent
dc.contributor.authorUnalp, Aycan
dc.date.accessioned2024-07-12T21:04:41Z
dc.date.available2024-07-12T21:04:41Z
dc.date.issued1998en_US
dc.departmentFakülteler, Tıp Fakültesien_US
dc.description.abstractBackground and aims of the study: Thrombosis is one of the most feared and life-threatening complications of mechanical heart valves (MHV), with an incidence of 1-3 per 100 patient-years. Hypercoagulable states are highly prevalent in the general population and can predispose MHV to thrombus formation. Thus, we conducted a study to investigate the frequency of hypercoagulable states in patients with MHV who had recurrent thrombosis at least twice after valve implantation. Methods: Fifteen patients (mean age 42 +/- 11 years; range: 18 to 55 years) with recurrent thrombosis of MHV (2.4 +/- 0.8 recurrences/patient) (group 1) and 15 matched patients (mean age 40 +/- 12 years; range: 18 to 55 years) with MHV without thrombosis (group 2) were followed up with transthoracic and transesophageal echocardiography. Patients' sera were monitored for antibodies to cardiolipin (ACLA-IgG and ACLA-IgM), phosphatidylserine (APSA), lupus-type anticoagulant (LA) and lipoprotein(a) (LP(a)). Results: Average values for group 1 versus group 2 were: ACLA-IgG (normal range < 15 GPLU/ml) 24.7 +/- 14.6 versus 6.2 +/- 2.7 (p < 0.001); ACLA-IgM (< 12.5 MPLU/ml) 7.9 +/- 5.0 versus 3.3 +/- 1.7 (u = 185; p < 0.001); APSA (< 12 RLU/ml) 4.8 +/- 5.7 and 2.9 +/- 1.2 (p = 0.56); and LP(a) (< 30 mg/dl) 36.5 +/- 26.5 and 13.4 +/- 7.1 (p < 0.001). The frequency of LA-positive cases was 4/15 in group 1 and 0/15 in group 2 (p > 0.05). The frequency of abnormally high levels of ACLA-IgG was 9/15 in group 1 and 0/15 in group 2 (p < 0.001); of ACLA-IgM, 2/15 in group 1 and 0/15 in group 2 (p > 0.05); of APSA, 1/15 in group 1 and 0/15 in group 2 (p > 0.05); and of LP(a), 5/15 in group 1 and 0/15 in group 2 (p < 0.05). At least one of the factors included in this study was abnormal in 14 of 15 (93%) patients (p < 0.0001). Conclusions: Hypercoagulable states are highly prevalent in patients with recurrent thrombosis of MHV. All patients evaluated for therapy of obstructive thrombosis of MHV should be investigated for hypercoagulable state. Moreover, in high-risk patients, surgical replacement of the MHV with a bioprosthesis should be considered.en_US
dc.identifier.citationGençbay, M., Turan, F., Değertekin, M., Ekşi Duran, N., Mutlu, B. ve Ünalp, A. (1998). High prevalence of hypercoagulable states in patients with recurrent thrombosis of mechanical heart valves. Journal of Heart Valve Disease. 7(6), s. 601-609.en_US
dc.identifier.endpage609en_US
dc.identifier.issue6en_US
dc.identifier.startpage601en_US
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/9870192/
dc.identifier.urihttps://hdl.handle.net/20.500.12415/3815
dc.identifier.volume7en_US
dc.institutionauthorEkşi Duran, Nilüfer
dc.language.isoenen_US
dc.publisherNational Library of Medicineen_US
dc.relation.ispartofJournal of Heart Valve Diseaseen_US
dc.relation.publicationcategoryUluslararası Hakemli Dergide Makale - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY01912
dc.titleHigh prevalence of hypercoagulable states in patients with recurrent thrombosis of mechanical heart valvesen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

Tıp Fakültesi Koleksiyonu